Dr. Cheryn Song Urology

Consultant - Urologist , Experience:

Book Appointment

About Doctor

Dr. Cheryn Song is among the top urologist in Seoul, South Korea. Dr. Cheryn Song is known for treatment of prostate cancer, kidney cancer & bladder cancer.

Dr. Cheryn Song education
  • Master of Public Health : Johns Hopkins University
  • Doctor of Medicine : University of Ulsan
  • Master of Medicine : University of Ulsan
  • Bachelor of Medicine : Yonsei University
Dr. Cheryn Song professional experiences
  • Fellow visiting investigator in Memorial Sloan Kettering Cancer Center Sidney Kimmel Center for Prostate and Urologic Cancers research , USA
  • Assistant Professor, Associate Professor in UUCM AMC
  • Clinical Instructor in UUCM AMC
  • Visiting Fellowship in Nagoya University Hospital, Japan
  • Fellowship in UUCM AMC
  • Residency in UUCM AMC


Asan Medical Centre, Seoul, South Korea


Procedures Performed

  • Prostate cancer treatment
  • Bladder cancer treatment
  • PCNL
  • RIRS
  • ESWL
  • Radical nephrectomy
  • Partial nephrectomy
  • Radical cystectomy
  • VVF / UVF repair

Research & Publications

Adaptive functional change of the contralateral kidney after partial nephrectomy.
Clinical outcome of high-dose bolus intravenous interleukin-2 with a modified administration schedule for Asian patients with metastatic renal cell carcinoma.
Clinicopathologic Characteristics and Prognosis of Xp11.2 Translocation Renal Cell Carcinoma: Multicenter, Propensity Score Matching Analysis.
Comparison of Hand-Assisted Laparoscopic vs Robot-Assisted Laparoscopic vs Open Partial Nephrectomy in Patients with T1 Renal Masses.
Comparison of postoperative pain between laparoscopic and robot-assisted partial nephrectomies for renal tumors: A propensity score matching analysis.
Does Ureteral Catheter Insertion Decrease the Risk of Urinary Leakage After Partial Nephrectomy in Patients With Renal Cell Carcinoma?
Fate of newly developed pulmonary embolism after surgery for renal cell carcinoma with vena cava thrombus.
Heterogeneous oncologic outcomes according to surgical pathology in high-risk prostate cancer: implications for better risk stratification and preoperative prediction of oncologic outcomes.
Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Obesity as a Risk Factor for Unfavorable Disease in Men with Low Risk Prostate Cancer and its Relationship with Anatomical Location of Tumor.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy